Big-money moves in the US on 23/01/23 (Mon)

Insider buys: 103 trades
Insider sales: 186 trades
Congress trades: 0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

Pangaea Three-B10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$237.5K
25,000 sh
$237.5K
Filed 23/01/23
Traded 23/01/23
CGC Sponsor10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$237.5K
25,000 sh
$237.5K
Filed 23/01/23
Traded 23/01/23
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column Group Opportunity III10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
Column Group Iii-A10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
Column Group III10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
Column Group III GP10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
TCG Opportunity III GP10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
Column Group Opportunity III GP10% Owner
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
EcoR1 Capital10% Owner
BuyZymeworks
Buy
Zymeworks
ZYME
$1.6M
163,400 sh
$1.6M
Filed 23/01/23
Traded 23/01/20
EcoR1 Capital10% Owner
BuyZymeworks
Buy
Zymeworks
ZYME
$1.4M
144,100 sh
$1.4M
Filed 23/01/23
Traded 23/01/19
Harriett J. Robinson10% Owner
BuyAtlantic American
Buy
Atlantic American
AAME
$900K
300,000 sh
$900K
Filed 23/01/23
Traded 22/12/30
BB Biotech10% Owner
BuyMacrogenics
Buy
Macrogenics
MGNX
$795K
150,000 sh
$795K
Filed 23/01/23
Traded 23/01/19
Target N. V. Biotech10% Owner
BuyMacrogenics
Buy
Macrogenics
MGNX
$795K
150,000 sh
$795K
Filed 23/01/23
Traded 23/01/19
Peter YuDirector
BuyAlTi Global
Buy
AlTi Global
ALTI
$237.5K
25,000 sh
$237.5K
Filed 23/01/23
Traded 23/01/23
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
David V. GoeddelDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$188.2K
37,639 sh
$188.2K
Filed 23/01/23
Traded 23/01/19
David V. GoeddelDirector
BuyTenaya Therapeutics
Buy
Tenaya Therapeutics
TNYA
$174.3K
69,739 sh
$174.3K
Filed 23/01/23
Traded 23/01/19
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$2,500
500 sh
$2,500
Filed 23/01/23
Traded 23/01/20